These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 4270696)

  • 21. Effect of growth of Walker 256 carcinosarcoma of the fibrinolytic system of the rat plasma and urine.
    Mootse G; Agostino D; Cliffton EE
    Tumori; 1970; 56(2):71-81. PubMed ID: 4248380
    [No Abstract]   [Full Text] [Related]  

  • 22. In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
    Bhuvarahamurthy V; Schroeder J; Denkert C; Kristiansen G; Schnorr D; Loening SA; Jung K; Staack A
    Oncol Rep; 2004 Oct; 12(4):909-13. PubMed ID: 15375521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The significance of fibrinolysis in abortion.
    Soma H
    Zasshi Tokyo Ika Daigaku; 1970 Mar; 28(2):343-50. PubMed ID: 4260254
    [No Abstract]   [Full Text] [Related]  

  • 24. [Studies on free radicals in tumor tissue of the urinary bladder. 1. Free radicals in human normal bladder mucosa and transitional cell carcinoma of the urinary bladder analyzed with electron spin resonance (ESR)].
    Matsunaga J
    Nihon Hinyokika Gakkai Zasshi; 1969 Mar; 60(3):214-30. PubMed ID: 4307319
    [No Abstract]   [Full Text] [Related]  

  • 25. [Expression of cyclooxygenase in bladder transitional cell carcinoma].
    Wang KJ; Li H; Wei Q; Yang YR
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):54-6. PubMed ID: 14981815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity of coagulation and fibrinolytic system components in the vein thrombus.
    Guzowski A; Gacko M; Worowska A; Kowalewski R; Ostapowicz R; Ploński A
    Adv Med Sci; 2006; 51():205-7. PubMed ID: 17357310
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [FIBRINOLYSIS AND ANTIFIBRINOLYTIC THERAPY IN UROLOGIC OPERATIONS. EXAMINATIONS USING A NEW METHOD FOR MEASURING FIBRINOLYSIS].
    PIPER W; BUCHBERGER HG; SIMON S; KRUEGER J
    Med Welt; 1965 Feb; 8():385-96. PubMed ID: 14262868
    [No Abstract]   [Full Text] [Related]  

  • 28. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH; Rijken DC
    Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
    Matsuo O; Rijken DC; Collen D
    Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arterio-venous differences in the components of the fibrinolytic enzyme system.
    Ogston D; Ogston CM; Bennett NB
    Thromb Diath Haemorrh; 1966 Jul; 16(1):32-7. PubMed ID: 4229628
    [No Abstract]   [Full Text] [Related]  

  • 31. Extraction of plasminogen activator in the rat's submaxillary gland.
    Lucas ON; Lucas GV
    Acta Physiol Pharmacol Ther Latinoam; 1995; 45(2):115-22. PubMed ID: 8580523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fibrinolysis--a review.
    Kane KK
    Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A study on fibrinolysis in experimental bladder tumors.
    Hisazumi H; Fukushima K
    Urol Res; 1973 Dec; 1(4):186-91. PubMed ID: 4789029
    [No Abstract]   [Full Text] [Related]  

  • 34. Substrate composition and the effect of epsilon-aminocaproic acid on tissue plasminogen activator and urokinase-induced fibrinolysis.
    Thorsen S; Astrup T
    Thromb Diath Haemorrh; 1974 Dec; 32(2-3):306-24. PubMed ID: 4281113
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro effects of lipids on fibrinolysis.
    Chopin SF; Beard EL
    Thromb Diath Haemorrh; 1973 May; 29(2):286-92. PubMed ID: 4357632
    [No Abstract]   [Full Text] [Related]  

  • 36. Formation of complexes of heparin with proteins and its physiological role. II.
    Lyapina LA; Ul'yanov AM
    Hum Physiol; 1979; 4(2):239-48. PubMed ID: 156146
    [No Abstract]   [Full Text] [Related]  

  • 37. Fibrinolysis and its control.
    Andersson L
    S Afr Med J; 1972 Feb; 46(8):182-5. PubMed ID: 4260535
    [No Abstract]   [Full Text] [Related]  

  • 38. [Association of uPA and uPAR expression with invasive behaviors of urinary transitional cell carcinoma].
    Li YJ; Zheng BZ; Zhou ZL
    Ai Zheng; 2004 Jun; 23(6):704-6. PubMed ID: 15191676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fibrinolytic homeostasis in pregnancy. I. Quantitative relations between pro- and anti-fibrinolytic factors. Clinical and experimental study].
    Giordano G
    Minerva Ginecol; 1969 Jul; 21(14):888-92. PubMed ID: 4249426
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on fibrinolytic enzymes in the field of obstetrics and gynecology, especially tissue activator. 4. Antifibrinolytic action of sex hormones, especially a conjugated estrogen (Premarin) and its application.
    Mori N; Takemoto J
    Acta Obstet Gynaecol Jpn; 1969 Jul; 16(3):137-42. PubMed ID: 4309742
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.